Back to Journals » Cancer Management and Research » Volume 11
Original Research
Concurrent proton-pump inhibitors increase risk of death for lung cancer patients receiving 1st-line gefitinib treatment - a nationwide population-based study
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
8,702 | Dovepress* | 7,029+ | 910 | 7,939 | |
PubMed Central* | 1,673 | 311 | 1,984 | ||
Totals | 8,702 | 1,221 | 9,923 | ||
*Since 19 September 2019 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
5 | 0 | 0 | 0 | 1 | 4 |
View citations on PubMed Central and Google Scholar